Veeda Lifesciences
Veeda Lifesciences is a global Contract Research Organisation (CRO) offering end-to-end drug development services — preclinical, bioanalytical, BA/BE, biopharma, and clinical trials Phase I–IV — to innovator pharma, generic drug, and biotech companies across 9 countries.
- Company typePrivate
- Founded-
- HeadquartersAhmedabad, India
- Headcount—
- GTM typeB2B
- OfferingServices
What Veeda Lifesciences does
Veeda Lifesciences is a global Contract Research Organisation (CRO) headquartered in Ahmedabad, India, providing end-to-end drug development services to pharmaceutical, biotechnology, and generic drug companies. Founded in 2004 as Veeda Clinical Research and rebranded to Veeda Lifesciences in January 2025, the company operates through 2,100+ professionals across 9 countries and 26 geographies, with subsidiaries including Bioneeds for preclinical services and Veeda Europe based in Athens. Its service portfolio spans preclinical (GLP toxicology, IND-enabling studies via Bioneeds), small molecule development (bioanalytical, BA/BE studies, complex generics), large molecule / biopharma services (analytical sciences, biological sciences, bioprocess development, clinical bioanalysis), and full-service clinical trials across Phase I–IV with a specialization in hemato-oncology.
The technology stack combines in-house platforms with industry-standard tools: a Clinical Trial Management System (CTMS) and Electronic Data Capture (EDC) systems supporting integrations with Medidata Rave, Oracle Clinical, Octalsoft, and Medrio; bioanalytical platforms including LC-MS/MS, ICP-OES, ICP-MS, and SFC-MS/MS with 1.2 million-sample annual processing capacity; an AI-powered patient matching system analyzing global EMR data; a Real-World Evidence database of 2 million+ oncology patient records; and advanced microsampling methods enabling 10–20 µL sample volumes. The company reports throughput gains of 30% from automated sample processing, bioanalytical study reports in under 3 weeks, and elimination of 10,000+ paper forms annually.
Veeda generates revenue through fee-for-service professional services contracts with enterprise pharmaceutical and biotech clients, selling project-based engagements rather than recurring subscriptions. GTM is direct enterprise field sales, supported by conference presence (BIO, CPHI, ASCO, ESMO, EHA, ASH), content marketing, webinars, and case studies. The company reports a 90%+ client retention rate and is recognized by USFDA, WHO, EMA, ANVISA, MHRA, and AGES, with 23,500+ GLP regulatory submissions completed via Bioneeds. The January 2025 rebrand and July 2025 AI investment in Mango Sciences signal a strategic pivot from a generics-focused Indian CRO toward a tech-driven, innovation-oriented global CRO spanning small molecules to biologics.
Veeda Lifesciences firmographics
Firmographics- Name
- Veeda Lifesciences
- Legal name
- Veeda Clinical Research Limited
- Website
- https://veedalifesciences.com
- Company type
- Private
- Operating status
- Operating
- Short description
- Veeda Lifesciences is a global Contract Research Organisation (CRO) offering end-to-end drug development services — preclinical, bioanalytical, BA/BE, biopharma, and clinical trials Phase I–IV — to innovator pharma, generic drug, and biotech companies across 9 countries.
- Ownership category
- akta.pro rank
Veeda Lifesciences industry classification
Industry- Product category
- Contract Research Organization (CRO) / Drug Development Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro industry
- Clinical CROs (Phase I–IV)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Patient Recruitment, Site Feasibility & Trial Enablement CROsHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Clinical Data Management, Biostatistics & Statistical Programming CROsHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)Pharmacovigilance, Risk Management & Medical Affairs CROsHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)
Keywords
Where Veeda Lifesciences is headquartered
LocationHeadquarters
- HQ city
- Ahmedabad
- HQ country
- India
- HQ region
- Asia
Offices5 records
Markets served
Veeda Lifesciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- CRO Services (Preclinical, Clinical, Bioanalytical): Fee-for-service model providing comprehensive contract research services including preclinical studies, bioanalytical services, BA/BE studies, and clinical trials (Phase I-IV). Revenue is generated through project-based contracts with pharmaceutical companies for drug development services. The company offers both standalone services and integrated end-to-end solutions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Veeda Lifesciences product offering
Product offeringCore offering
Veeda Lifesciences is a global contract research organization (CRO) providing integrated drug development services to pharmaceutical and biopharma clients. Its core offerings include clinical trial management (Phase II–IV), bioanalytical and pharmacokinetic studies, biopharmaceutical development, central laboratory/diagnostic services, clinical data management and biostatistics, site management, and real-world evidence studies. The company delivers these services across 9 countries and 26 geographies, leveraging AI/analytics-enabled platforms and a workforce of 2,100+ professionals.
Product overview
Veeda Lifesciences is a global Contract Research Organization (CRO) offering integrated, end-to-end drug development services as a unified platform spanning from discovery through market approval. The portfolio includes preclinical services (via subsidiary Bioneeds), small molecule development, biopharma/large molecule services (Veeda Biopharma), bioanalytical services, BA/BE studies, complex generics development, and full-service clinical trials across all phases. Central Services provides biometrics, regulatory affairs, project management, and medical writing support, while Real World Evidence Services enables AI-powered patient recruitment. The company operates across 9 countries with 26 geographic sites and a global team of 2,100+ professionals.
Differentiator
Problem solved
Functional benefit
Brands
- Bioneeds: Preclinical research services subsidiary offering GLP toxicology, IND-enabling studies, and regulatory compliant data. Operating as 'Bioneeds, a Veeda Lifesciences company'.
Products and services
- Clinical Trial Management (Phase II–IV)
Quantifiable outcome
- 30% throughput improvement from automated sample processing systems
- +6 more outcomes
Companies that use Veeda Lifesciences
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles1 record
Veeda Lifesciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability7 records
Feature8 records
Veeda Lifesciences partnerships and signals
Strategic signalScale indicators14 records
Recent moves7 records
Expansion highlights6 records
Veeda Lifesciences competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Largest global CRO and healthcare data/analytics company. Competes across Veeda's clinical trial, RWE, and biopharma service lines but with substantially greater scale, proprietary data assets, and technology investment.
- Syneos Health: Global biopharma solutions organization spanning clinical development and commercial services. Direct overlap with Veeda's clinical trial operations and full-service offerings.
- Parexel International: Global CRO serving biopharma with clinical, regulatory, real-world evidence, and biopharma services. Direct overlap with Veeda's full-service clinical and central services portfolio.
- Labcorp Drug Development (Fortrea): Spun out from Labcorp, Fortrea operates a global CRO across clinical, bioanalytical, and central lab services. Direct overlap with Veeda's clinical trials and bioanalytical service lines.
- ICON plc: Top-3 global CRO providing clinical research, biometrics, and laboratory services. Direct competitor for Veeda's Phase I-IV and central services offerings across pharma and biotech sponsors.
Direct peers
- Syngene International: India-headquartered, publicly listed CRO offering discovery, development, and manufacturing services to global pharma. Most direct comparable by geography, scale (~5,000+ employees), and integrated service model.
- Medpace: Mid-size, science-focused global CRO with strong therapeutic-area expertise and full-service clinical offerings. Comparable mid-market positioning with similar focus on complex therapeutic areas.
- Pharmaron: China-based global CRO/CDMO with integrated drug discovery, preclinical, clinical, and biologics services. Comparable end-to-end service model and Asian-headquartered global delivery structure.
- Charles River Laboratories: Global CRO with strong preclinical/early-stage research focus (analogous to Veeda's Bioneeds subsidiary), plus biologics services. Most comparable to Veeda's preclinical and biopharma capabilities.
- WuXi AppTec: Asia-headquartered global CRO/CDMO offering preclinical, clinical, and biologics services. Comparable integrated service model and Asia-cost-base delivery structure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Veeda Lifesciences social profiles
Digital presenceVeeda Lifesciences compliance and trust
Trust signalCompliance11 records
Veeda Lifesciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Veeda Lifesciences leadership team
Management profileNumber of profiles
Profiles8 records
Veeda Lifesciences subsidiaries and ownership
Company hierarchySubsidiaries2 records
Veeda Lifesciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Veeda Lifesciences M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Veeda Lifesciences
What does Veeda Lifesciences do?
Veeda Lifesciences is a global contract research organization (CRO) providing integrated drug development services to pharmaceutical and biopharma clients. Its core offerings include clinical trial management (Phase II–IV), bioanalytical and pharmacokinetic studies, biopharmaceutical development, central laboratory/diagnostic services, clinical data management and biostatistics, site management, and real-world evidence studies. The company delivers these services across 9 countries and 26 geographies, leveraging AI/analytics-enabled platforms and a workforce of 2,100+ professionals.
Is Veeda Lifesciences a public or private company?
Veeda Lifesciences is a private company. It is classified as public and is currently operating.
When was Veeda Lifesciences founded?
Veeda Lifesciences was founded in -1.
Where is Veeda Lifesciences based?
Veeda Lifesciences is headquartered in Ahmedabad, India, in the Asia region.
How does Veeda Lifesciences make money?
One revenue line is on record: CRO Services (Preclinical, Clinical, Bioanalytical).
Who are Veeda Lifesciences's main competitors?
Broad incumbents on record are IQVIA, Syneos Health, Parexel International, Labcorp Drug Development (Fortrea) and ICON plc. Direct peers are Syngene International, Medpace, Pharmaron, Charles River Laboratories and WuXi AppTec.
Does Veeda Lifesciences have an API?
No public API is recorded for Veeda Lifesciences.
What industry is Veeda Lifesciences in?
Veeda Lifesciences's product category is Contract Research Organization (CRO) / Drug Development Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.